What is the recommended dose of cinnarizine (per kg body weight) for motion sickness in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Cinnarizine for Motion Sickness in Children

The recommended dosage of cinnarizine for motion sickness in children is 15 mg (one tablet) given 2 hours before travel, with an additional half-tablet (7.5 mg) every 8 hours as needed during extended journeys. 1

Dosing Guidelines by Age

  • For children susceptible to motion sickness, a single 15 mg cinnarizine tablet should be administered approximately 2 hours before the journey begins 1
  • For extended journeys, an additional half-tablet (7.5 mg) can be given every 8 hours as needed 1
  • This dosing regimen has shown good efficacy with 81% of children rating the treatment as "good" or "excellent" in clinical studies 1

Safety Considerations

  • Cinnarizine is generally well-tolerated in children at the recommended dosage, with only 14% of children experiencing mild drowsiness or sleepiness 1
  • Only 4% of children experienced vomiting when taking cinnarizine at the recommended dosage 1
  • Caution is warranted as severe overdose can cause serious neurological complications including stupor, twitching, and seizures 2
  • A documented case of cinnarizine toxicity occurred in a 30-month-old who ingested 225 mg (18 times the recommended dose), resulting in stupor, twitching, and seizures 2

Pharmacokinetics and Timing

  • The onset of action for cinnarizine is slower than some other motion sickness medications, with effects typically occurring 5-7 hours after administration 3
  • This slower onset necessitates administration well before travel begins 3
  • The elimination half-life of cinnarizine in a pediatric overdose case was calculated to be approximately 3.65 hours 2

Efficacy Compared to Other Treatments

  • In children who had previously used other motion sickness medications, 69% rated cinnarizine as "better" or "much better" than their previous treatments 1
  • Antihistamines like cinnarizine are probably more effective than placebo at preventing motion sickness symptoms under natural conditions (40% vs 25% prevention rate) 4
  • When compared to scopolamine, the evidence regarding comparative efficacy is uncertain 4

Monitoring and Precautions

  • Children should be monitored for potential side effects, particularly sedation, which may occur more frequently with antihistamines compared to placebo (66% vs 44%) 4
  • Cognitive impairment and blurred vision appear to be less common side effects with antihistamines used for motion sickness 4
  • In case of suspected overdose, children should be observed in a healthcare facility for potential neurological complications 2

Clinical Application Tips

  • For optimal effectiveness, ensure the medication is given 2 hours before travel begins 1
  • Consider the duration of the journey when determining if additional doses will be needed 1
  • The medication appears to be most effective when used prophylactically rather than after symptoms have begun 1
  • Physicians who have prescribed cinnarizine for children with motion sickness have reported high satisfaction, with nearly all willing to prescribe it again based on clinical experience 1

References

Research

Cinnarizine in the prophylaxis of car sickness in children.

Current medical research and opinion, 1983

Research

Time-course of effects of oral cinnarizine and hyoscine on task performance.

Journal of psychopharmacology (Oxford, England), 1989

Research

Antihistamines for motion sickness.

The Cochrane database of systematic reviews, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.